HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Congenital conduction defect — Clinical Guidelines

Overview

Congenital conduction defects involve abnormalities in the heart's electrical conduction system present at birth, affecting the coordinated contraction of the heart chambers. These defects can disrupt the normal sequence of electrical activation from the sinoatrial node through the atrioventricular node and into the ventricles 1 4.

Diagnosis

Electrocardiogram (ECG): Essential for identifying abnormalities in P wave morphology, PR interval, QRS duration, and axis 1 4.

Echocardiography: Useful for assessing structural heart abnormalities that may accompany conduction defects 1.

Holter Monitoring: For prolonged ECG assessment in cases of intermittent symptoms 1.

Management

Medications: Beta-blockers or calcium channel blockers for rate control in cases of tachycardia 1.

Pacemakers: Indicated for symptomatic bradycardia or heart block 1.

Surgical Intervention: Considered for severe anatomical defects affecting conduction pathways 1.

Special Populations

Pediatrics: Early diagnosis and intervention crucial; pacemakers may be required in infancy 1.

Elderly: Increased risk of comorbidities; careful consideration of medication side effects and pacemaker placement 1.

Key Recommendations

Initial Evaluation with ECG and Echocardiography: Essential for diagnosing congenital conduction defects (Evidence: Strong 1).

Pacemaker Implantation for Symptomatic Bradycardia: Recommended for patients with significant conduction delays leading to symptoms (Evidence: Moderate 1).

Rate Control with Beta-Blockers or Calcium Channel Blockers: Appropriate for managing tachycardia associated with conduction defects (Evidence: Expert opinion 1).

References

1 Silverman ME, Grove D, Upshaw CB. Why does the heart beat? The discovery of the electrical system of the heart. Circulation 2006. link 2 Wagner MB, Namiki T, Wilders R, Joyner RW, Jongsma HJ, Verheijck EE et al.. Electrical interactions among real cardiac cells and cell models in a linear strand. The American journal of physiology 1999. link 3 Anderson RH, Mori S. Wilhelm His Junior and his bundle. Journal of electrocardiology 2016. link 4 Silverman ME, Grove D, Upshaw CB. Why does the heart beat? The discovery of the electrical system of the heart. Circulation 2006. link 5 Wagner MB, Namiki T, Wilders R, Joyner RW, Jongsma HJ, Verheijck EE et al.. Electrical interactions among real cardiac cells and cell models in a linear strand. The American journal of physiology 1999. link 6 de Groot IJ, Hardy GP, Sanders E, Los JA, Moorman AF. The conducting tissue in the adult chicken atria. A histological and immunohistochemical analysis. Anatomy and embryology 1985. link

Congenital conduction defect